Ed Miseta, for the Clinical Leader wrote, (excerpt)

The study, titled Content That Clicks: Effective Social Marketing for Clinical Trial Recruitment, notes four key findings. First, the recall rate of clinical trial ads is high. In other words, patients who see these ads will later recall having seen them. This is certainly different than most traditional advertising efforts. Sixty-six percent of epilepsy patient respondents and a whopping 79 percent of migraine respondents recalled seeing clinical trial advertising.

When asked where they recall seeing the ads, most respondents cited television ads, followed by Facebook, and their doctor’s office. Other sources garnering over 20 percent of responses by either epilepsy or migraine patients were online patient communities, search engines, newspapers, and radio. LinkedIn was cited by just 8 percent of epilepsy patients and 0.6 percent of migraine patients. Respondents were also asked what social media platforms they use regularly to read or post content. YouTube was number one, followed by Pinterest, Instagram, Twitter, and LinkedIn.

The study found that high trial intenders have a significant trust of social media. High trial intenders are defined as individuals who indicated a high intent to enroll in a clinical trial. These individuals showed high levels of trust in every digital information source outlined in the study, including YouTube, Facebook, Instagram, and Twitter. In terms of the level of trust placed in these sources, most social media channels were clustered closely together. YouTube was the most trusted channel. In fact, trust in YouTube amongst those with high intent to enroll in a trial was 19 percent higher than those with low intent.

In general we find similar assessments.  You can read the entirety of Ed Miseta’s article by clicking here.